
Insights from Bayer’s $1.5 Billion VC Fund | Lucio Iannone, Head of Health Venture Investments (VP) at Leaps by Bayer
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
Core Investment Principles: Need, Science, Syndicate
Jess asks for lessons learned; Lucio lays out priorities: medical need, credible science, strong syndicate, and CEO capability to scale.
Transcript
Play full episode